Mental health issues, such as depression and substance use, often peak during the holidays, but research has shown that just ...
COVID-19 continues to retreat from being a top cause of death in the U.S., and in turn, life expectancy last year rebounded further toward pre-pandemic longevity.
The FDA has approved a new drug called ensartinib for adults with a type of lung cancer called ALK-positive non-small-cell lung cancer (NSCLC).
New CDC data shows that in a survey, 24% of adults said they had pain most days or every day during the past three months.
Does your family make you sick at the holidays? We’re not just talking about catching a bug. It’s the emotional toll, which ...
The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.